Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment
Highly
anticipated data on Gilead's novel twice yearly HIV treatment have been
announced, suggesting that the therapy is effective in heavily
pretreated ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.